PDFファイル - 医薬品医療機器総合機構
Contents
1. 15 000 Xx g 10 1 Lp a 1g L 3 BN BN I BN HI Lp a g L 27 5 27 5 27 5 74 95 742. Lp a Lp a Lp a a LDL a 3 Lp 8 CHD Lp a CHD
3. lt 1g L BN
4. N Lp a SY OQCVO5 N Lp a SY OQCWO5 NN JPOO083 JPO0082 4 1 BN N Lp 2mL X3 2 30 N Latex Lp a Reagent 3 2 8C a Lp 4 BN 1g L
5. BN 5 N Lp a SY BN N a N Lp a SY Lp 8 Lp a
6. HIV HBV HCV lt 0 196 8C 18
7. Lp a 5 3 N Lp a SY 6 Lp a 0 29 1 77 g L 20 n 20 Lp a IN Lp a 1 1 3 gL 043 029 061 1 77 1 040 0 29 0 57 1 10 SD g L 0 08 001 10 08 10 04 001 001 0 01 0 02 CV 41 21 24 1 21 26 18 ga1 2 N Lp a a 0 17 1 75 g L 10 n 10 SY 5 Lp N Lp 8 NLp a 1 3 4 5 g L 0 43 0 28 0 59 1 75 0 43 0 17 0 84 SD g L 0 01 0 01 0 0
8. 3 1 1 a 0 04mg dL 809 6 8 80 15096 3 a 2 3 CV 1596 4 0 1 1 6 g L 400 1 0g mL 0 005g L N 60 ug mL n 20 2SD B 19 596 Apo a
9. N Lp a 0QHL11 mLX3 1 Koschinsky ML Marcovina SM Lipoprotein a structural implications for pathophysiology Int J Clin Lab Hes 1997 27 14 23 2 Danesh J Collins R Peto R Lipoprotein a and coronary heart disease Meta analysis of prospective studies Circulation 2000 102 1082 5 3 Craig WY Neveux LM Palomaki GE et al Lipoprotein a asa risk factor for ischemic heart disease metaanalysis of prospective studies Clin Chem 1998 44 2301 6 4 Kostner GM Avogaro P Cazzolato G et al Lipoprotein Lp a and the risk for myocardial infarction Atherosclerosis 1981 38 51 61 5 Marcovina SM Albers JJ Scanu AM et al Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein a Clin Chem 2000 46 1956 67 TEL 03 3483 8400 1 1 1 1 DL 113 034E OQHL G11 E0502
10. 4 5 0 C 1 N Lp a SY 2 1 1 6g L 600mg L 10g L
11. N Lp a SY BN Lp a N 400 2 BN 1 BN 7 BN g L 8C 7
12. 95 74 95 1 0 04 lt 0 0g 0 05 lt 0 02 0 04 lt 0 08 N Lp a 1 2 mL 828 a 331 el 297 ae Ey 30 Lp a 015 1004 011 004 01 100g 4o gt gt 78 e4 lt o 51 1 09 051 114 0 50 1 08 gg 594 008 094 008 003 002 8C 0 24 0 53 0 25 0 53 0 23 0 46 LD 8 8C 2 Lp g 0 3g L 75
13. 8 0 06 0 08 0 01 0 04 CV 3 1 3 5 28 3 5 5 3 i 4 2 y x 0 02 lt 1 31g L Passing Bablok y 0 92x 0 005g L 0 96 86 3 1 HIV HBV HCV IVD Directive HIV 1 HIV 2 HBV HCV
14. SIEMENS OQHL 11 a A EE 4 N Latex Lp a Reagent 20800AMY10001000 BN 1 8 5 BNH BN 3 BN BN BNT BN
Download Pdf Manuals
Related Search